Filter Results
:
(9,781)
Show Results For
-
All HBS Web
(9,781)
- People (21)
- News (2,007)
- Research (6,153)
- Events (32)
- Multimedia (42)
- Faculty Publications (4,368)
Show Results For
-
All HBS Web
(9,781)
- People (21)
- News (2,007)
- Research (6,153)
- Events (32)
- Multimedia (42)
- Faculty Publications (4,368)
- June 2018
- Case
Forta Furniture: International Expansion
By: John A. Quelch and Karthik Easwar
The Forta Furniture case highlights the need to consider new market expansion to grow a firm. It demonstrates that simply doing what has always been done is not sustainable when other competitors enter the market with differentiated or potentially superior offerings....
View Details
Keywords:
Market Entry and Exit;
Global Range;
Decision Making;
Analysis;
Cross-Cultural and Cross-Border Issues;
Growth and Development Strategy;
Brands and Branding;
Expansion
Quelch, John A., and Karthik Easwar. "Forta Furniture: International Expansion." Harvard Business School Brief Case 918-547, June 2018.
- 17 Oct 2017
- First Look
First Look at New Research and Ideas, October 17, 2017
Publisher's link: https://pubwww.hbs.edu/faculty/Pages/item.aspx?num=53346 November–December 2017 Research-Technology Management Innovation Streams and Executive Leadership By: Tushman, Michael...
View Details
Keywords:
Sean Silverthorne
- 15 Aug 2017
- First Look
First Look at New Research and Ideas, August 15, 2017
2017 Washington, DC: American Public Health Association Public Health Preparedness: Case Studies in Policy and Management By: Howitt, Arnold M., Dutch Leonard, and David W....
View Details
Keywords:
Sean Silverthorne
- April 2024 (Revised April 2024)
- Case
Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight Loss Drugs
By: Joseph L. Badaracco, Tom Quinn and John Schultz
Danish pharmaceutical company Novo Nordisk was owned by a charitable foundation, and since its founding in the 1920s had focused on producing insulin to treat diabetes. In 2017, however, it released Ozempic, a diabetes treatment with the revolutionary side effect of...
View Details
Keywords:
Cost vs Benefits;
Decisions;
Judgments;
Values and Beliefs;
Global Strategy;
Health Care and Treatment;
Patents;
Growth and Development Strategy;
Growth Management;
Product Positioning;
Supply and Industry;
Supply Chain;
Corporate Social Responsibility and Impact;
Mission and Purpose;
Philanthropy and Charitable Giving;
Opportunities;
Social Issues;
Equality and Inequality;
Pharmaceutical Industry;
Health Industry;
Denmark;
United States;
Europe;
China;
India;
Middle East;
North Africa
- Fast Answer
Digital Innovation and Transformation: Resources useful for Course Assignments
style="border-bottom:1px solid black; width:534px; padding:0in 7px 0in 7px; border-top:1px solid black; border-right:1px solid black; border-left:none" valign="top"> Provides articles on various digital transformation related business...
View Details
- Article
Hurry or Wait: The Pros and Cons of Going Fast or Slow on Climate Change
By: Eleanor Denny and Jurgen Weiss
Climate change risk will likely force the de-carbonization of our electricity sector and thus involve massive investments in long-lived assets using many new and emerging technologies. Since technological progress (independent or dependent on deployment) will likely...
View Details
Keywords:
Electricity Sector;
Environmental Risks;
Fat Tails;
Greenhouse Gas Emissions;
Climate Change;
Information Technology;
Investment;
Technological Innovation;
Cost vs Benefits
Denny, Eleanor, and Jurgen Weiss. "Hurry or Wait: The Pros and Cons of Going Fast or Slow on Climate Change." Economists' Voice 12, no. 1 (August 2015): 19–24.
- 23 May 2011
- Op-Ed
Leading and Lagging Countries in Contributing to a Sustainable Society
at the number of times investors accessed environmental and social data on Bloomberg terminals and ranked countries based on the number of "hits," accounting for the size of each country's capital market. We...
View Details
Keywords:
by Robert G. Eccles & George Serafeim
- 09 Aug 2021
- Research & Ideas
OneTen: Creating a New Pathway for Black Talent
learned first-hand about this inequity as a child in Philadelphia’s public schools. During a recent interview with Manny Maceda, Bain & Company’s worldwide managing partner, Frazier reflected on his experience: “My younger sister...
View Details
- Web
U.S. Competitiveness Project - Institute For Strategy And Competitiveness
the U.S. economy. The Looming Challenge to U.S. Competitiveness In a March 2012 article of the Harvard Business Review, Professors Michael Porter and Jan Rivkin outlined the looming challenge to U.S. competitiveness. The United States is...
View Details
- 2008
- Other Unpublished Work
From Public Purpose to Financial Economics: The Linked Ecologies of Economics and Business in Twentieth Century America
By: Marion Fourcade and Rakesh Khurana
As the main producers of managerial elites, business schools represent strategic research sites for understanding the formation of economic practices and representations. This article draws on historical material to analyze the changing place of economics in American...
View Details
- 29 Aug 2011
- Research & Ideas
Decoding Insider Information and Other Secrets of Old School Chums
pricing. Hedge fund firms often hired the duo for speaking engagements, which led to informal post-speech chats with various fund managers, many of whom also sported PhDs. Cohen and Malloy found that these...
View Details
- 16 Jan 2018
- First Look
First Look at New Research and Ideas, January 16, 2018
virtually all the gains to be had go to those that create an ownership culture, by building in participative management and helping employees learn to think and act like...
View Details
Keywords:
Sean Silverthorne
- 08 May 2018
- First Look
First Look at New Research and Ideas, May 8, 2018
forthcoming Management Science Evidence of Upcoding in Pay-for-Performance Programs By: Bastani, Hamsa, Joel Goh, and Mohsen Bayati Abstract—Recent Medicare legislation seeks to improve patient care quality...
View Details
Keywords:
Sean Silverthorne
William R. Kerr
William Kerr is the D’Arbeloff Professor of Business Administration at Harvard Business School. Bill is Senior Associate Dean for Faculty Development and Research, co-director of Harvard’s Managing the Future of Work initiative, and faculty chair of the... View Details
- January 2018 (Revised October 2021)
- Case
Château Margaux: Launching the Third Wine (Abridged)
By: Elie Ofek
Château Margaux, one of only five prestigious estates in the Bordeaux Medoc wine region to have been classified as a "first-growth", is facing a host of strategic decisions in early 2013. Up until this point the estate had been selling two red wines, a first wine whose...
View Details
Keywords:
New Product Launch;
Marketing Plan;
Brand Management;
Go To Market Strategy;
Channels Of Distribution;
Wine Industry;
Marketing Strategy;
Distribution Channels;
Product Launch;
Brands and Branding;
Agriculture and Agribusiness Industry;
Agriculture and Agribusiness Industry;
France
Ofek, Elie. "Château Margaux: Launching the Third Wine (Abridged)." Harvard Business School Case 518-070, January 2018. (Revised October 2021.)
- Web
IFC: Israel; Startups and Venture Capital - Course Catalog
5.(3:10PM-5:10PM). Travel Dates: Arrive Sunday, January 5 and Depart Thursday, January 16 Course Fee: $4,000 Immersive Field Courses: IFCs require a firm commitment and carry a...
View Details
- May 1995 (Revised September 1997)
- Case
Internationalizing the Cola Wars (A): The Battle for China and Asian Markets
By: David B. Yoffie
Analyzes the strategies pursued by Coke and Pepsi in the emerging Asian soft drink market. Analyzes the tactical battle of the cola giants in China specifically.
View Details
Keywords:
Trade;
Emerging Markets;
Corporate Strategy;
Competition;
Globalized Firms and Management;
Food and Beverage Industry;
China;
Asia
Yoffie, David B. "Internationalizing the Cola Wars (A): The Battle for China and Asian Markets." Harvard Business School Case 795-186, May 1995. (Revised September 1997.)
- 13 Sep 2018
- HBS Seminar
Nitin Joglekar, Boston University
- February 2015 (Revised November 2015)
- Case
Building an Integrated Biopharma Company: Crucell (A)
By: Richard G. Hamermesh, Marianne Van Der Steen and Susan S. Harmeling
By 2009, Crucell had become the largest biopharma company in the Netherlands and a symbol of national pride. The case traces the evolution of the company from a University spin-off into a fully-integrated company. Crucell's success, particularly in the vaccine space,...
View Details
Keywords:
Biotechnology;
Biopharmacy Company;
Licensing;
Licensing Agreements In Biopharmacy;
Human Cell-line Technology;
Vaccine;
Healthcare Innovation;
Global Health;
Partners and Partnerships;
Entrepreneurship;
Growth and Development Strategy;
Biotechnology Industry;
Pharmaceutical Industry;
Netherlands
Hamermesh, Richard G., Marianne Van Der Steen, and Susan S. Harmeling. "Building an Integrated Biopharma Company: Crucell (A)." Harvard Business School Case 815-085, February 2015. (Revised November 2015.)